Search results
Training Brain Cells to Stop Epileptic Seizures
WJMN Marquette via Yahoo News· 3 days agoSAN DIEGO, Calif. (Ivanhoe Newswire) – More than three million Americans suffer from epilepsy. Not knowing when or if a seizure will strike can make...
Sudden unexpected death in epilepsy - 'warning signs were missed'
BBC News· 4 days agoKimberley Shepherd said she was dedicating her life to keeping her son Liam's memory alive following...
Novotech Report Analyses Epilepsy Research Trends Finding More than 4,000 Clinical Trials Conducted...
Benzinga· 19 hours agoBOSTON, June 20, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel
Takeda flunks pivotal epilepsy tests but mulls path to market for Ovid-partnered prospect
FierceBiotech· 4 days agoTakeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. The drug candidate, the cholesterol ...
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
Zacks via Yahoo Finance· 3 days agoOvid’s partner Takeda...respectively. While the SKYLINE study narrowly missed out on its primary...
Takeda’s epilepsy drug misses the mark in two Phase III trials
Clinical Trials Arena via Yahoo Finance· 4 days agoTwo Phase III studies of Takeda’s epilepsy drug soticlestat for patients with the rare epilepsies...
Takeda's seizure drug fails to meet main goal in late-stage studies
Reuters via AOL· 4 days agoThe drug, soticlestat, was being tested in combination with standard-of-care treatment in adults and...
Existing high blood pressure drugs may prevent epilepsy, study finds
Medical Xpress· 3 days ago"This is incredibly exciting because we don't currently have any medicines that prevent epilepsy," said Kimford Meador, MD, a professor of neurology and the neurosciences ...
Takeda’s epilepsy drug misses main goals in late-stage trials - Boston Business Journal
The Business Journals· 4 days agoTakeda Pharmaceuticals Inc. shared disappointing results from two late-stage trials for rare forms...
Woman Has Not Gone a Day Without Migraine in Over 4 Years: Inside Her Life with Debilitating...
People via Yahoo News· 6 hours ago"People see migraine as separate events, when sometimes there is actually a chronic cause —...